These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22483603)

  • 1. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia.
    Blunt MD; Ward SG
    Curr Opin Pharmacol; 2012 Aug; 12(4):444-51. PubMed ID: 22483603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of small molecule SHIP phosphatase modulators.
    Viernes DR; Choi LB; Kerr WG; Chisholm JD
    Med Res Rev; 2014 Jul; 34(4):795-824. PubMed ID: 24302498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
    Ngoh EN; Weisser SB; Lo Y; Kozicky LK; Jen R; Brugger HK; Menzies SC; McLarren KW; Nackiewicz D; van Rooijen N; Jacobson K; Ehses JA; Turvey SE; Sly LM
    Gastroenterology; 2016 Feb; 150(2):465-76. PubMed ID: 26481854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
    Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
    Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning T lymphocytes: a role for the lipid phosphatase SHIP-1.
    Parry RV; Harris SJ; Ward SG
    Biochim Biophys Acta; 2010 Mar; 1804(3):592-7. PubMed ID: 19782768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.
    Blunt MD; Ward SG
    Front Immunol; 2012; 3():226. PubMed ID: 22876243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer.
    Condé C; Gloire G; Piette J
    Biochem Pharmacol; 2011 Nov; 82(10):1320-34. PubMed ID: 21672530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies.
    Foster JG; Blunt MD; Carter E; Ward SG
    Pharmacol Rev; 2012 Oct; 64(4):1027-54. PubMed ID: 23023033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation.
    Maxwell MJ; Srivastava N; Park MY; Tsantikos E; Engelman RW; Kerr WG; Hibbs ML
    Genes Immun; 2014 Apr; 15(4):233-40. PubMed ID: 24598798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SHIP in cancer.
    Hamilton MJ; Ho VW; Kuroda E; Ruschmann J; Antignano F; Lam V; Krystal G
    Exp Hematol; 2011 Jan; 39(1):2-13. PubMed ID: 21056081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents.
    Ward SG; Finan P
    Curr Opin Pharmacol; 2003 Aug; 3(4):426-34. PubMed ID: 12901953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.
    Scharenberg AM; El-Hillal O; Fruman DA; Beitz LO; Li Z; Lin S; Gout I; Cantley LC; Rawlings DJ; Kinet JP
    EMBO J; 1998 Apr; 17(7):1961-72. PubMed ID: 9524119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells.
    Mancini A; Koch A; Wilms R; Tamura T
    Oncogene; 2002 Feb; 21(10):1477-84. PubMed ID: 11896575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
    Wain CM; Westwick J; Ward SG
    Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility.
    Harris SJ; Parry RV; Foster JG; Blunt MD; Wang A; Marelli-Berg F; Westwick J; Ward SG
    J Immunol; 2011 Apr; 186(8):4936-45. PubMed ID: 21402888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor and activator: dual functions for SHIP in immunity and cancer.
    Kerr WG
    Ann N Y Acad Sci; 2011 Jan; 1217():1-17. PubMed ID: 21155837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
    Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
    Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.